352 related articles for article (PubMed ID: 23096708)
1. Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes.
Yoon JY; Kwon HH; Min SU; Thiboutot DM; Suh DH
J Invest Dermatol; 2013 Feb; 133(2):429-40. PubMed ID: 23096708
[TBL] [Abstract][Full Text] [Related]
2. Salicylic acid treats acne vulgaris by suppressing AMPK/SREBP1 pathway in sebocytes.
Lu J; Cong T; Wen X; Li X; Du D; He G; Jiang X
Exp Dermatol; 2019 Jul; 28(7):786-794. PubMed ID: 30972839
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes.
Im M; Kim SY; Sohn KC; Choi DK; Lee Y; Seo YJ; Kim CD; Hwang YL; Zouboulis CC; Lee JH
J Invest Dermatol; 2012 Dec; 132(12):2700-8. PubMed ID: 22763784
[TBL] [Abstract][Full Text] [Related]
4. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression.
Nakatsuji T; Kao MC; Zhang L; Zouboulis CC; Gallo RL; Huang CM
J Invest Dermatol; 2010 Apr; 130(4):985-94. PubMed ID: 20032992
[TBL] [Abstract][Full Text] [Related]
5. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
[TBL] [Abstract][Full Text] [Related]
6. Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.
Sato T; Shirane T; Noguchi N; Sasatsu M; Ito A
J Dermatol; 2012 Sep; 39(9):774-80. PubMed ID: 22394009
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of sebum production and Propionibacterium acnes lipase activity by fullerenol, a novel polyhydroxylated fullerene: potential as a therapeutic reagent for acne.
Inui S; Aoshima H; Ito M; Kobuko K; Itami S
J Cosmet Sci; 2012; 63(4):259-65. PubMed ID: 23193890
[TBL] [Abstract][Full Text] [Related]
8. [Use of organic acids in acne and skin discolorations therapy].
Kapuścińska A; Nowak I
Postepy Hig Med Dosw (Online); 2015 Mar; 69():374-83. PubMed ID: 25811473
[TBL] [Abstract][Full Text] [Related]
9. Polyphenon-60 displays a therapeutic effect on acne by suppression of TLR2 and IL-8 expression via down-regulating the ERK1/2 pathway.
Jung MK; Ha S; Son JA; Song JH; Houh Y; Cho E; Chun JH; Yoon SR; Yang Y; Bang SI; Kim M; Park HJ; Cho D
Arch Dermatol Res; 2012 Oct; 304(8):655-63. PubMed ID: 22684779
[TBL] [Abstract][Full Text] [Related]
10. Acne and Propionibacterium acnes.
Bojar RA; Holland KT
Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
[TBL] [Abstract][Full Text] [Related]
11. Suppression of
Lee EH; Shin JH; Kim SS; Joo JH; Choi E; Seo SR
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31319552
[TBL] [Abstract][Full Text] [Related]
12. Topical Treatment With an Agent Disruptive to P. acnes Biofilm Provides Positive Therapeutic Response: Results of a Randomized Clinical Trial.
Bernhardt MJ; Myntti MF
J Drugs Dermatol; 2016 Jun; 15(6):677-83. PubMed ID: 27272073
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata.
Leyden JJ; McGinley KJ; Foglia AN
J Invest Dermatol; 1986 Apr; 86(4):390-3. PubMed ID: 2943823
[TBL] [Abstract][Full Text] [Related]
14. Propionibacterium acnes stimulates pro-matrix metalloproteinase-2 expression through tumor necrosis factor-alpha in human dermal fibroblasts.
Choi JY; Piao MS; Lee JB; Oh JS; Kim IG; Lee SC
J Invest Dermatol; 2008 Apr; 128(4):846-54. PubMed ID: 18049448
[TBL] [Abstract][Full Text] [Related]
15. Activity-guided purification identifies lupeol, a pentacyclic triterpene, as a therapeutic agent multiple pathogenic factors of acne.
Kwon HH; Yoon JY; Park SY; Min S; Kim YI; Park JY; Lee YS; Thiboutot DM; Suh DH
J Invest Dermatol; 2015 Jun; 135(6):1491-1500. PubMed ID: 25647437
[TBL] [Abstract][Full Text] [Related]
16. Preventative effects of antioxidants on changes in sebocytes, outer root sheath cells, and
Kwack MH; Ha DL; Lee WJ
Int J Immunopathol Pharmacol; 2022; 36():3946320221112433. PubMed ID: 35778860
[TBL] [Abstract][Full Text] [Related]
17. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
20. The role of facial sebum secretion in acne pathogenesis: facts and controversies.
Youn SW
Clin Dermatol; 2010; 28(1):8-11. PubMed ID: 20082943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
